Drug establishment registration
GlaxoSmithKline Biologicals SA
FDA drug establishment · DUNS 372748392 · FEI 3002875226 · BEL
Key facts
| Firm name | GlaxoSmithKline Biologicals SA |
|---|---|
| DUNS number | 372748392 |
| FEI number | 3002875226 |
| Address | Rue de l'Institut 89, Rixensart, B-1330, Belgium (BEL) |
| Country | BEL |
| Business operations | ANALYSIS, LABEL, MANUFACTURE, PACK, STERILIZE |
| Registration valid through | Dec 31, 2026 |
At a glance
- Current Registration current
- 10–99 FDA inspections at this FEI
- 10–99 Inspections with a Form 483
- None Warning letters
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug establishment registrations
Establishments that manufacture, repack, relabel or analyze drugs for the U.S. market register with the FDA each year. The registration lists the site's DUNS and FEI numbers and its business operations.
Source: U.S. Food and Drug Administration (FDA), Drug Establishments Current Registration Site (DECRS)